World-renowned scientists and technologists building the future of medicine.
C-Suite
Dr. Siddhartha Mukherjee
Co-Founder & CEO
Ujjwal Singh
Co-Founder & CTO
Dr. Jonathan Baell
Chief Scientific Officer
Erez Kalir
Chief Operating Officer
Guided by extraordinary scientific minds
Our Scientific Advisory Board brings together Nobel laureates, National Academy members, and pioneering researchers who have shaped modern medicine and chemistry.
6
National Academy of Sciences Members
5
National Academy of Medicine Members
5
National Academy of Engineering Members
1
Nobel Laureate
2
Breakthrough Prize
15+
Companies Founded
Scientific Advisory Board
Dr. Matthew Shair
Harvard University
World leading organic chemist, small molecule therapeutics expert, and scientific founder of Nuvalent (Nasdaq: NUV).
Dr. Peter Kim
Stanford University
Pioneering biochemist and former President of Merck Research Laboratories, where he oversaw approval of over 20 new medicines.
Dr. Craig Mello
UMass Chan Medical School
Co-discoverer of RNA interference and 2006 Nobel Laureate in Medicine. Co-founder Aithea tx, scientific co-founder of CRISPR tx, Atalanta tx, and several others.
Dr. William Jorgensen
Yale University
World leading innovator in computational chemistry whose contributions have transformed molecular simulation and drug design.
Dr. Lewis Cantley
Harvard University
Discoverer of PI3K and PTEN, scientific founder of Agios Pharma (Nasdaq: AGIO).
Dr. Charles Sawyers
Howard Hughes Medical Institute
Lasker co-recipient for ABL kinase inhibitors, co-discovery of enzalutamide and apalutamide for prostate cancer.
Dr. David Spiegel MD
Yale University
Chemical biologist renowned for his contributions in antibody-recruiting molecules and synthetic antibody mimics for therapeutic applications.
Board of Directors
Dr. Siddhartha Mukherjee
Co-Founder of Manas AI, Prof. Oncology at Columbia University (On-Leave), Founder of Vor Bio (Nasdaq: VOR)
Reid Hoffman
Co-Founder of Manas AI, Co-Founder & Chairman of LinkedIn, Partner at Greylock
Erez Kalir
Founder & CEO of Martial Eagle Fund, Venture Partner at FJ Labs
Dr. Peter Kim
Prof. Biochemistry at Stanford University, Former President of Merck Research Labs
Ken Frazier
Chairman of Health Initiatives at General Catalyst, Former President & CEO of Merck & Co.
Mike Volpi
Retired Partner of Index Ventures
Join our team. Help Manas shape the future of drug discovery.
Reach out